Lamotrigine Patent Expiration
Lamotrigine was first introduced by Glaxosmithkline Llc
Lamotrigine Patents
Given below is the list of patents protecting Lamotrigine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Lamictal Odt | US7919115 | Orally disintegrating tablet compositions of lamotrigine | Jan 04, 2029 | Glaxosmithkline Llc |
| Lamictal Odt | US8840925 | Orally disintegrating tablet compositions of lamotrigine | Jul 02, 2028 | Glaxosmithkline Llc |
| Lamictal Odt | US9339504 | Orally disintegrating tablet compositions of lamotrigine | Jul 02, 2028 | Glaxosmithkline Llc |
| Lamictal Xr | US8637512 | Formulations and method of treatment | Jun 14, 2028 | Glaxosmithkline Llc |
| Lamictal Xr | US9144547 | Oral dosage form for controlled drug release |
Sep 22, 2023
(Expired) | Glaxosmithkline Llc |
| Lamictal Cd |
US5698226 (Pediatric) | Water-dispersible tablets |
Jul 29, 2012
(Expired) | Glaxosmithkline Llc |
Lamotrigine's Family Patents
Explore Our Curated Drug Screens
Lamotrigine Generics
Several generic applications have been filed for Lamotrigine. The first generic version for Lamotrigine was by Teva Pharmaceuticals Usa Inc and was approved on Jun 21, 2006. And the latest generic version is by Amring Pharmaceuticals Inc and was approved on Feb 3, 2022.
Given below is the list of companies who have filed for Lamotrigine generic.
1. ACTAVIS ELIZABETH
Actavis Elizabeth Llc has filed for 6 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | tablet, extended release | Prescription | ORAL | AB | Oct 17, 2013 |
| 25MG | tablet, extended release | Prescription | ORAL | AB | Oct 17, 2013 |
| 50MG | tablet, extended release | Prescription | ORAL | AB | Oct 17, 2013 |
| 300MG | tablet, extended release | Prescription | ORAL | AB | Oct 17, 2013 |
| 200MG | tablet, extended release | Prescription | ORAL | AB | Oct 17, 2013 |
| 250MG | tablet, extended release | Prescription | ORAL | AB | Nov 13, 2013 |
2. ACTAVIS TOTOWA
Actavis Totowa Llc has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Actavis Totowa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 200MG | tablet | Discontinued | ORAL | N/A | Apr 8, 2011 |
| 25MG | tablet | Discontinued | ORAL | N/A | Apr 8, 2011 |
| 100MG | tablet | Discontinued | ORAL | N/A | Apr 8, 2011 |
| 150MG | tablet | Discontinued | ORAL | N/A | Apr 8, 2011 |
3. AJANTA PHARMA LTD
Ajanta Pharma Ltd has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 50MG | tablet, orally disintegrating | Prescription | ORAL | AB | Jan 19, 2021 |
| 25MG | tablet, orally disintegrating | Prescription | ORAL | AB | Jan 19, 2021 |
| 200MG | tablet, orally disintegrating | Prescription | ORAL | AB | Jan 19, 2021 |
| 100MG | tablet, orally disintegrating | Prescription | ORAL | AB | Jan 19, 2021 |
4. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Alembic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | tablet, for suspension | Prescription | ORAL | AB | Jun 12, 2014 |
| 5MG | tablet, for suspension | Prescription | ORAL | AB | Jun 12, 2014 |
5. ALEMBIC PHARMS LTD
Alembic Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Alembic Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | tablet | Prescription | ORAL | AB | Jan 13, 2011 |
| 100MG | tablet | Prescription | ORAL | AB | Jan 13, 2011 |
| 150MG | tablet | Prescription | ORAL | AB | Jan 13, 2011 |
| 200MG | tablet | Prescription | ORAL | AB | Jan 13, 2011 |
6. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | tablet | Prescription | ORAL | AB | Jun 14, 2013 |
| 200MG | tablet | Prescription | ORAL | AB | Jun 14, 2013 |
| 150MG | tablet | Prescription | ORAL | AB | Jun 14, 2013 |
| 100MG | tablet | Prescription | ORAL | AB | Jun 14, 2013 |
7. AMNEAL PHARMS
Amneal Pharmaceuticals Of New York Llc has filed for 6 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Amneal Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | tablet, extended release | Prescription | ORAL | AB | Nov 30, 2018 |
| 50MG | tablet, extended release | Prescription | ORAL | AB | Nov 30, 2018 |
| 200MG | tablet, extended release | Prescription | ORAL | AB | Nov 30, 2018 |
| 100MG | tablet, extended release | Prescription | ORAL | AB | Nov 30, 2018 |
| 300MG | tablet, extended release | Prescription | ORAL | AB | Nov 30, 2018 |
| 250MG | tablet, extended release | Prescription | ORAL | AB | Nov 30, 2018 |
8. AMRING PHARMS
Amring Pharmaceuticals Inc has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Amring Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | tablet, orally disintegrating | Prescription | ORAL | AB | Feb 3, 2022 |
| 25MG | tablet, orally disintegrating | Prescription | ORAL | AB | Feb 3, 2022 |
| 50MG | tablet, orally disintegrating | Prescription | ORAL | AB | Feb 3, 2022 |
| 200MG | tablet, orally disintegrating | Prescription | ORAL | AB | Feb 3, 2022 |
9. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 5 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | tablet, for suspension | Prescription | ORAL | AB | Nov 4, 2009 |
| 100MG | tablet | Prescription | ORAL | AB | Jan 27, 2009 |
| 150MG | tablet | Prescription | ORAL | AB | Jan 27, 2009 |
| 200MG | tablet | Prescription | ORAL | AB | Jan 27, 2009 |
| 5MG | tablet, for suspension | Prescription | ORAL | AB | Nov 4, 2009 |
10. CHARTWELL MOLECULAR
Chartwell Molecular Holdings Llc has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Chartwell Molecular.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 150MG | tablet | Discontinued | ORAL | N/A | Nov 1, 2010 |
| 100MG | tablet | Discontinued | ORAL | N/A | Nov 1, 2010 |
| 25MG | tablet | Discontinued | ORAL | N/A | Nov 1, 2010 |
| 200MG | tablet | Discontinued | ORAL | N/A | Nov 1, 2010 |
11. DR REDDYS LABS LTD
Dr Reddys Laboratories Ltd has filed for 8 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | tablet, extended release | Prescription | ORAL | AB | Jun 19, 2013 |
| 5MG | tablet, for suspension | Prescription | ORAL | AB | Jan 22, 2009 |
| 100MG | tablet, extended release | Prescription | ORAL | AB | Jun 19, 2013 |
| 150MG | tablet | Prescription | ORAL | AB | Jan 27, 2009 |
| 200MG | tablet, extended release | Prescription | ORAL | AB | Jun 19, 2013 |
| 50MG | tablet, extended release | Prescription | ORAL | AB | Jun 19, 2013 |
| 300MG | tablet, extended release | Prescription | ORAL | AB | Jun 19, 2013 |
| 250MG | tablet, extended release | Prescription | ORAL | AB | Sep 6, 2018 |
12. ENDO OPERATIONS
Endo Operations Ltd has filed for 6 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Endo Operations.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 300MG | tablet, extended release | Prescription | ORAL | AB | Jan 18, 2013 |
| 250MG | tablet, extended release | Prescription | ORAL | AB | Jan 18, 2013 |
| 200MG | tablet, orally disintegrating | Prescription | ORAL | AB | Oct 27, 2015 |
| 100MG | tablet, orally disintegrating | Prescription | ORAL | AB | Oct 27, 2015 |
| 50MG | tablet, orally disintegrating | Prescription | ORAL | AB | Oct 27, 2015 |
| 25MG | tablet, orally disintegrating | Prescription | ORAL | AB | Oct 27, 2015 |
13. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 5 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | tablet | Prescription | ORAL | AB | May 4, 2012 |
| 5MG | tablet, for suspension | Prescription | ORAL | AB | Feb 19, 2009 |
| 150MG | tablet | Prescription | ORAL | AB | May 4, 2012 |
| 100MG | tablet | Prescription | ORAL | AB | May 4, 2012 |
| 200MG | tablet | Prescription | ORAL | AB | May 4, 2012 |
14. GRANULES
Granules India Ltd has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Granules.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | tablet | Discontinued | ORAL | N/A | Jan 27, 2009 |
| 100MG | tablet | Discontinued | ORAL | N/A | Jan 27, 2009 |
| 150MG | tablet | Discontinued | ORAL | N/A | Jan 27, 2009 |
| 200MG | tablet | Discontinued | ORAL | N/A | Jan 27, 2009 |
15. HIKMA PHARMS
Hikma Pharmaceuticals has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Hikma Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | tablet | Discontinued | ORAL | N/A | Apr 19, 2011 |
| 150MG | tablet | Discontinued | ORAL | N/A | Apr 19, 2011 |
| 100MG | tablet | Discontinued | ORAL | N/A | Apr 19, 2011 |
| 200MG | tablet | Discontinued | ORAL | N/A | Apr 19, 2011 |
16. IMPAX LABS INC
Impax Laboratories Inc has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Impax Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | tablet, orally disintegrating | Discontinued | ORAL | N/A | Jul 15, 2013 |
| 25MG | tablet, orally disintegrating | Discontinued | ORAL | N/A | Jul 15, 2013 |
| 50MG | tablet, orally disintegrating | Discontinued | ORAL | N/A | Jul 15, 2013 |
| 200MG | tablet, orally disintegrating | Discontinued | ORAL | N/A | Jul 15, 2013 |
17. JUBILANT CADISTA
Jubilant Cadista Pharmaceuticals Inc has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Jubilant Cadista.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | tablet | Prescription | ORAL | AB | Jan 27, 2009 |
| 100MG | tablet | Prescription | ORAL | AB | Jan 27, 2009 |
| 150MG | tablet | Prescription | ORAL | AB | Jan 27, 2009 |
| 200MG | tablet | Prescription | ORAL | AB | Jan 27, 2009 |
18. JUBILANT GENERICS
Jubilant Generics Ltd has filed for 2 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Jubilant Generics.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet, for suspension | Discontinued | ORAL | N/A | Feb 28, 2011 |
| 25MG | tablet, for suspension | Discontinued | ORAL | N/A | Feb 28, 2011 |
19. LUPIN LTD
Lupin Ltd has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | tablet | Prescription | ORAL | AB | Jun 1, 2010 |
| 200MG | tablet | Prescription | ORAL | AB | Jun 1, 2010 |
| 25MG | tablet | Prescription | ORAL | AB | Jun 1, 2010 |
| 150MG | tablet | Prescription | ORAL | AB | Jun 1, 2010 |
20. NATCO PHARMA
Natco Pharma Ltd has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Natco Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | tablet | Discontinued | ORAL | N/A | Jan 27, 2009 |
| 100MG | tablet | Discontinued | ORAL | N/A | Jan 27, 2009 |
| 150MG | tablet | Discontinued | ORAL | N/A | Jan 27, 2009 |
| 200MG | tablet | Discontinued | ORAL | N/A | Jan 27, 2009 |
21. NORVIUM BIOSCIENCE
Norvium Bioscience Llc has filed for 5 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet, for suspension | Discontinued | ORAL | N/A | Jan 22, 2009 |
| 25MG | tablet | Discontinued | ORAL | N/A | Feb 11, 2009 |
| 200MG | tablet | Discontinued | ORAL | N/A | Feb 11, 2009 |
| 150MG | tablet | Discontinued | ORAL | N/A | Feb 11, 2009 |
| 100MG | tablet | Discontinued | ORAL | N/A | Feb 11, 2009 |
22. RISING
Rising Pharma Holding Inc has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Rising.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | tablet | Discontinued | ORAL | N/A | Jan 27, 2009 |
| 100MG | tablet | Discontinued | ORAL | N/A | Jan 27, 2009 |
| 150MG | tablet | Discontinued | ORAL | N/A | Jan 27, 2009 |
| 200MG | tablet | Discontinued | ORAL | N/A | Jan 27, 2009 |
23. ROXANE
Roxane Laboratories Inc has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Roxane.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | tablet | Discontinued | ORAL | N/A | Jan 27, 2009 |
| 100MG | tablet | Discontinued | ORAL | N/A | Jan 27, 2009 |
| 150MG | tablet | Discontinued | ORAL | N/A | Jan 27, 2009 |
| 200MG | tablet | Discontinued | ORAL | N/A | Jan 27, 2009 |
24. RUBICON
Rubicon Research Private Ltd has filed for 5 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Rubicon.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | tablet, extended release | Prescription | ORAL | AB | Jun 17, 2013 |
| 25MG | tablet, extended release | Discontinued | ORAL | N/A | Jun 17, 2013 |
| 150MG | tablet | Prescription | ORAL | AB | Jan 27, 2009 |
| 200MG | tablet, extended release | Prescription | ORAL | AB | Jun 17, 2013 |
| 50MG | tablet, extended release | Discontinued | ORAL | N/A | Jun 17, 2013 |
25. SANDOZ
Sandoz Inc has filed for 5 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Sandoz.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | tablet | Discontinued | ORAL | N/A | Jan 27, 2009 |
| 5MG | tablet, for suspension | Discontinued | ORAL | N/A | Jan 22, 2009 |
| 100MG | tablet | Discontinued | ORAL | N/A | Jan 27, 2009 |
| 150MG | tablet | Discontinued | ORAL | N/A | Jan 27, 2009 |
| 200MG | tablet | Discontinued | ORAL | N/A | Jan 27, 2009 |
26. SCIEGEN PHARMS INC
Sciegen Pharmaceuticals Inc has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 200MG | tablet, orally disintegrating | Prescription | ORAL | AB | Jun 17, 2016 |
| 25MG | tablet, orally disintegrating | Prescription | ORAL | AB | Jun 17, 2016 |
| 50MG | tablet, orally disintegrating | Prescription | ORAL | AB | Jun 17, 2016 |
| 100MG | tablet, orally disintegrating | Prescription | ORAL | AB | Jun 17, 2016 |
27. TARO
Taro Pharmaceutical Industries Ltd has filed for 2 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Taro.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | tablet, for suspension | Prescription | ORAL | AB | Feb 4, 2009 |
| 5MG | tablet, for suspension | Prescription | ORAL | AB | Feb 4, 2009 |
28. TARO PHARM INDS
Taro Pharmaceutical Industries Ltd has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Taro Pharm Inds.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | tablet | Prescription | ORAL | AB | Jan 27, 2009 |
| 100MG | tablet | Prescription | ORAL | AB | Jan 27, 2009 |
| 150MG | tablet | Prescription | ORAL | AB | Jan 27, 2009 |
| 200MG | tablet | Prescription | ORAL | AB | Jan 27, 2009 |
29. TEVA
Teva Pharmaceuticals Usa Inc has filed for 5 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Teva.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet, for suspension | Discontinued | ORAL | N/A | Jun 21, 2006 |
| 25MG | tablet | Discontinued | ORAL | N/A | Aug 30, 2006 |
| 150MG | tablet | Discontinued | ORAL | N/A | Aug 30, 2006 |
| 200MG | tablet | Discontinued | ORAL | N/A | Aug 30, 2006 |
| 100MG | tablet | Discontinued | ORAL | N/A | Aug 30, 2006 |
30. TORRENT
Torrent Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Torrent.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 50MG | tablet, extended release | Prescription | ORAL | AB | Dec 23, 2013 |
| 100MG | tablet, extended release | Prescription | ORAL | AB | Dec 23, 2013 |
| 25MG | tablet, extended release | Prescription | ORAL | AB | Dec 23, 2013 |
| 200MG | tablet, extended release | Discontinued | ORAL | N/A | Dec 23, 2013 |
31. TORRENT PHARMS
Torrent Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Torrent Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | tablet | Prescription | ORAL | AB | Jan 27, 2009 |
| 100MG | tablet | Prescription | ORAL | AB | Jan 27, 2009 |
| 150MG | tablet | Prescription | ORAL | AB | Jan 27, 2009 |
| 200MG | tablet | Prescription | ORAL | AB | Jan 27, 2009 |
32. UNICHEM LABS LTD
Unichem Laboratories Ltd has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Unichem Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 200MG | tablet | Prescription | ORAL | AB | Oct 6, 2011 |
| 25MG | tablet | Prescription | ORAL | AB | Oct 6, 2011 |
| 100MG | tablet | Prescription | ORAL | AB | Oct 6, 2011 |
| 150MG | tablet | Prescription | ORAL | AB | Oct 6, 2011 |
33. WATSON LABS
Watson Laboratories Inc has filed for 3 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Watson Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | tablet, for suspension | Prescription | ORAL | AB | Jan 22, 2009 |
| 5MG | tablet, for suspension | Prescription | ORAL | AB | Jan 22, 2009 |
| 2MG | tablet, for suspension | Prescription | ORAL | AB | Jan 22, 2009 |
34. WOCKHARDT BIO AG
Wockhardt Bio Ag has filed for 5 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Wockhardt Bio Ag.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 50MG | tablet, extended release | Prescription | ORAL | AB | Jan 4, 2013 |
| 300MG | tablet, extended release | Prescription | ORAL | AB | Jan 4, 2013 |
| 200MG | tablet, extended release | Prescription | ORAL | AB | Jan 4, 2013 |
| 100MG | tablet, extended release | Prescription | ORAL | AB | Jan 4, 2013 |
| 25MG | tablet, extended release | Prescription | ORAL | AB | Jan 4, 2013 |
35. YILING
Yiling Pharmaceutical Ltd has filed for 6 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Yiling.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 250MG | tablet, extended release | Prescription | ORAL | AB | Dec 8, 2021 |
| 100MG | tablet, extended release | Prescription | ORAL | AB | Dec 8, 2021 |
| 50MG | tablet, extended release | Prescription | ORAL | AB | Dec 8, 2021 |
| 25MG | tablet, extended release | Prescription | ORAL | AB | Dec 8, 2021 |
| 300MG | tablet, extended release | Prescription | ORAL | AB | Dec 8, 2021 |
| 200MG | tablet, extended release | Prescription | ORAL | AB | Dec 8, 2021 |
36. ZENNOVA
Zennova Pharmaceuticals Chengdu Co Ltd has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Zennova.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | tablet | Discontinued | ORAL | N/A | Feb 4, 2009 |
| 25MG | tablet | Discontinued | ORAL | N/A | Feb 4, 2009 |
| 200MG | tablet | Discontinued | ORAL | N/A | Feb 4, 2009 |
| 150MG | tablet | Discontinued | ORAL | N/A | Feb 4, 2009 |
37. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 6 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 200MG | tablet, extended release | Prescription | ORAL | AB | Apr 1, 2020 |
| 100MG | tablet, extended release | Prescription | ORAL | AB | Apr 1, 2020 |
| 50MG | tablet, extended release | Prescription | ORAL | AB | Apr 1, 2020 |
| 25MG | tablet, extended release | Prescription | ORAL | AB | Apr 1, 2020 |
| 300MG | tablet, extended release | Prescription | ORAL | AB | Apr 1, 2020 |
| 250MG | tablet, extended release | Prescription | ORAL | AB | Apr 1, 2020 |
38. ZYDUS PHARMS USA
Zydus Pharmaceuticals Usa Inc has filed for 6 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Zydus Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | tablet | Prescription | ORAL | AB | Jan 27, 2009 |
| 50MG | tablet | Prescription | ORAL | N/A | Jan 27, 2009 |
| 100MG | tablet | Prescription | ORAL | AB | Jan 27, 2009 |
| 150MG | tablet | Prescription | ORAL | AB | Jan 27, 2009 |
| 200MG | tablet | Prescription | ORAL | AB | Jan 27, 2009 |
| 250MG | tablet | Prescription | ORAL | N/A | Jan 27, 2009 |
39. ZYDUS PHARMS USA INC
Zydus Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Zydus Pharms Usa Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | tablet, for suspension | Prescription | ORAL | AB | Jan 22, 2009 |
| 5MG | tablet, for suspension | Prescription | ORAL | AB | Jan 22, 2009 |